Vimta Labs Limited announced its unaudited financial results for the second quarter and half year ended September 30, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance - Q2 FY27
- Total Income: ₹1,149 million, representing a 1.8% quarter-on-quarter increase from Q1 FY27 (₹1,129 million) and a 9.9% year-on-year increase from Q2 FY26 (₹1,045 million)
- EBITDA (including other income): ₹408 million, showing a slight decrease of 0.8% from Q1 FY27 (₹411 million) but a 10.5% increase from Q2 FY26 (₹369 million)
- EBITDA Margin: 35.5%, compared to 36.4% in Q1 FY27 and 35.3% in Q2 FY26
- PBT: ₹275 million (disclosed in highlights section)
- PAT (continued operations): ₹206 million, representing a 2.0% decrease from Q1 FY27 (₹210 million) but a 3.5% increase from Q2 FY26 (₹199 million)
- PAT Margin: 17.9%, compared to 18.6% in Q1 FY27 and 19.1% in Q2 FY26
- Basic EPS: ₹4.6, showing a 2.1% decrease from Q1 FY27 (₹4.7) but a 3.4% increase from Q2 FY26 (₹4.5)
Financial Performance - H1 FY27
- Total Income: ₹2,278 million, representing an 11.8% increase from H1 FY26 (₹2,038 million)
- EBITDA (including other income): ₹819 million, representing a 13.2% increase from H1 FY26 (₹723 million)
- EBITDA Margin: 36.0%, compared to 35.5% in H1 FY26
- PBT: ₹559 million (disclosed in highlights section)
- PAT (continued operations): ₹417 million, representing a 7.3% increase from H1 FY26 (₹388 million)
- PAT Margin: 18.3%, compared to 19.0% in H1 FY26
- Basic EPS: ₹9.3, representing a 7.0% increase from H1 FY26 (₹8.7)
Management Commentary
Ms. Harita Vasireddi, Managing Director, commented on the results:
- Q2 FY27 marked another quarter of steady, profitable growth
- Pharmaceutical and food research and testing services continue to anchor growth
- The start of revenue from biologics CRAD services represents a significant milestone that broadens scientific capabilities
- The company is well positioned for the second half with favorable industry environment, expanded infrastructure, and diversified portfolio
- Confidence in delivering sustained growth and creating long-term value for stakeholders
Cautionary Statement
The press release contains forward-looking statements subject to known and unknown risks and uncertainties. Actual results may differ substantially from expected future results. No warranties are made as to the accuracy of such statements, and the company has no obligation to update any information or correct inaccuracies.